Vistagen Therapeutics, Inc. (VTGN)
4.57
+0.28
(+6.53%)
USD |
NASDAQ |
Dec 09, 15:55
Vistagen Therapeutics Market Cap: 180.49M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 357.53M |
| XOMA Royalty Corp. | 398.18M |
| Omeros Corp. | 813.23M |
| GeoVax Labs, Inc. | 11.65M |
| Daré Bioscience, Inc. | 26.72M |
Market Cap Related Metrics
| PS Ratio | 160.40 |
| PEG Ratio | -0.1175 |
| Price to Book Value | 2.721 |
| Price | 4.57 |
| Earnings Yield | -41.53% |
| PEGY Ratio | -0.1175 |